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Objectives. We sought to determine a range of cutpoints for
coronary calcium scores measured by electron beam computed
tomography (EBCT) in predicting the likely severity of associated
angiographic coronary artery stenoses.
Background. EBCT can quantify coronary calcium and allow
the estimation of atherosclerotic plaque burden, but use of the
calcium score to define lumen narrowing is controversial.
Methods. A total of 213 patients (mean [6SD] age 50 6 9
years) underwent coronary angiography and EBCT. Maximal
percent diameter stenosis in any artery was paired with total
coronary calcium score. Receiver operating characteristic (ROC)
curve analysis was done using definitions of “disease” for maxi-
mal stenosis from >220% to 100%, and the corresponding score
cutpoints were determined for 90% sensitivity, 90% specificity or
“optimal” sensitivity and specificity.
Results. ROC curve areas ranged from a mean (6SE) of 0.91 6
0.02 for >220% stenosis to 0.83 6 0.03 for 100% stenosis. Optimal
calcium score cutpoints consisted of nonoverlapping values rang-
ing from 15 for >220% stenosis to 327 for 100% stenosis, whereas
sensitivities and specificities ranged from 78% to 84%, depending
on maximal stenosis severity. Calcium score cutpoints for 90%
sensitivity and 90% specificity were also nonoverlapping and
ranged from 3 and 27, respectively, for >220% stenosis to 154 and
945, respectively, for 100% stenosis; corresponding specificities
and sensitivities ranged from 40% to 78%.
Conclusions. These data define the ranges for EBCT coronary
calcium score cutpoints that predict the likely severity of associ-
ated maximal angiographic stenosis severity to a high sensitivity,
high specificity or optimal sensitivity/specificity. These cutpoints
potentially can be used in conjunction with clinical variables to
predict the severity of lumen narrowing in patients undergoing
assessment for coronary artery disease.
(J Am Coll Cardiol 1997;29:1542–8)
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Coronary artery calcium is closely associated with mural
atheromatous plaque (1–4), and electron beam computed
tomography (EBCT) has been extensively evaluated regarding
its noninvasive identification and quantification. A direct rela-
tion has been established between coronary artery calcium
area, as measured by EBCT or histologic study, or both, and
atherosclerotic plaque area on a heart by heart, vessel by vessel
and coronary segment by segment basis (5–7). However,
guidelines regarding measurements or estimates of coronary
mural plaque as a standard for clinical disease severity have
not been established. Currently, most clinicians gauge the
extent of coronary artery disease according to measures deter-
mined at angiography, or they use surrogate estimates of
disease severity based on results of noninvasive stress testing.
Previous studies have shown a positive relation between the
amount of calcified coronary plaque measured by EBCT
(either using the coronary “calcium area” or “calcium score”
[8]) and the anatomic severity of coronary lumen narrowing
(9–11). However, there is not a one-to-one relation between
plaque and percent stenosis. Clinicians are then faced with a
dilemma when attempting to relate the “calcium score” with
the likely severity of any associated coronary lumen stenoses.
Therefore, application of positive results from EBCT coronary
artery studies indicating how calcium scores may relate to the
anatomic extent of coronary artery narrowing in the clinical
setting has been controversial.
The purpose of the current study was to discover whether
specific ranges of values, or “cutpoints,” regarding EBCT
coronary artery calcium scores could be determined to predict
with a high sensitivity or specificity, or both, the likely severity
of associated coronary stenoses, as compared with direct
coronary angiography. To accomplish this, results from 213
consecutive patients who had no previously documented cor-
onary artery disease but who had undergone both angiography
and EBCT were analyzed using receiver operating character-
istic (ROC) curve analysis.
Methods
EBCT. EBCT, also known as ultrafast computed tomogra-
phy (CT) (Imatron C-100, C-150) and cine-CT, uses a station-
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ary source/detector pair whereby X-rays are produced as a
rotating electron beam is swept across a series of one to four
semicircular tungsten targets. There are no moving parts to the
imaging chain, and scanning through or at preset times during
the cardiac cycle is possible in rapid succession. For identifi-
cation of coronary artery calcium, consecutive, single-slice,
3-mm thick, 100-ms scans are performed. In this “high resolu-
tion” volume scanning mode, 40 sequential tomograms of the
heart in synchrony with the heart rate during late diastole can
be completed in as many cardiac cycles. Depending on the
pulse rate, two serial breath holds may be required to acquire
scans from the root of the aorta and the origin of the left main
coronary artery through distal portions of the right coronary
artery. In-plane spatial resolution (using a 300-mm field of
view) is 0.4 mm2. Identification of coronary artery calcium
requires no intravenous contrast injection because calcification
of arterial walls demonstrates relatively high Hounsfield (H)
densities, 2- to 10-fold greater than the surrounding soft tissue.
Thus, the appearance of high density intramural coronary
calcium deposits adjacent to low density soft tissue and sur-
rounding fat made visual identification of calcium for determi-
nation of calcium content of the coronary arteries by EBCT
relatively straightforward.
Patient group. To make a direct comparison between
EBCT-derived coronary artery calcium and the likely severity
of coronary angiographic disease, results from patients who
underwent both EBCT scanning and direct coronary angiog-
raphy at the Mayo Clinic were analyzed. The angiographic/
EBCT study was approved by the local Institutional Review
Board. The patient group consisted of men and women who
had no previously documented history of obstructive coronary
artery disease and were scheduled by their cardiologist for a
diagnostic coronary angiogram. No patient had unstable an-
gina or underwent angioplasty at the time of angiography.
Results from subsets of this patient group have been published
previously (9,10,12).
Individual patients were approached an average of 1 day
after angiography for consent to perform an EBCT scan.
Two-hundred thirteen consecutive patients (152 men and 51
women, average age 50 6 9 years) were included in the
analysis. One hundred sixty patients (75%) underwent angiog-
raphy for assessment of chest pain; 25 (12%) had abnormal
stress tests; 17 (8%) had unexplained heart failure; and 11
(5%) had a questionable history of previous infarction, peri-
carditis or unexplained dyspnea. Coronary angiography was
performed by the Judkins technique with a minimum of five
views of the left coronary system and two views of the right
coronary system. The absence or presence of discrete coronary
artery stenoses was visually assessed by two angiographers, and
the maximal percent diameter stenosis in any epicardial coro-
nary artery was defined as 0% to ,20% (none or trivial),
$20%, $30%, $40%, $50%, $60%, $70%, $80%, $90% or
100% stenosis. In case of a disagreement in the interpretation
of a given coronary angiogram, it was read by a third cardiol-
ogist, and the maximal degree of stenosis was arbitrated.
EBCT scan analysis. A number of studies have confirmed
that coronary artery calcium detected by EBCT is a very
sensitive test for coronary atherosclerotic plaque (7) and for
“significant” coronary lumen disease (i.e., $50% diameter or
$75% area stenoses) (9,10,13), with a negative predictive
value of 90% or better (9,10,13,14). However, the specificity of
a positive test (any coronary calcification) for obstructive
coronary artery disease has been considered too poor to
advocate EBCT as a primary test to predict the severity of
lumen disease. However, the coronary artery calcium content,
or “score,” originally introduced by Agatston et al. (8), is a
continuous variable that may be more helpful in predicting the
likely severity of lumen narrowing than merely the absence or
presence of coronary calcium.
Each EBCT scan was analyzed in a fashion as previously
discussed (9,10,12). For each study, a calcium score was
determined using the methods of Agatston et al. (8). This
algorithm has been widely used in research and clinical studies.
The calcium score is the product of the area of calcification (at
least two contiguous pixels [9]) per coronary segment and a
factor rated 1 through 4 dictated by the maximal calcium
Hounsfield density within that segment. A calcium score was
calculated for each epicardial coronary segment and recorded
as a composite (i.e., total or summed) score for the entire
epicardial coronary system (left main, left anterior descending,
left circumflex and right coronary arteries).
ROC curve analysis was used as an extension of traditional
sensitivity and specificity analyses (9,13,15,16) to establish
relations between total coronary calcium score measured by
EBCT and maximal severity of coronary artery stenosis mea-
sured by angiography. Based on the analysis, an ROC curve
was constructed that plotted the “true positive rate” (i.e.,
sensitivity) as the dependent y-variable for all measured cal-
cium scores and the “false positive rate” (i.e., 1 2 Specificity)
as the independent x-variable at any given definition of disease
(i.e., maximal angiographic lumen narrowing). ROC analyses
were repeated with the same data set using a variable defini-
tion of disease based on maximal angiographic stenosis versus
all values of total EBCT coronary calcium scores in the data
set. Thresholds for angiographic lumen disease were $20%,
$30%, $40%, $50%, $60%, $70%, $80%, $90% and
100% maximal stenoses.
Statistics. ROC curve analysis was done using True Epistat
(17) installed on a desktop computer. Data for individual
maximal coronary stenoses determined by angiography and
corresponding total EBCT calcium score for each patient were
entered into parallel columns using a spreadsheet program and
then imported in analysis of variance format into True Epistat.
The statistical analyses were repeated for variable definitions
Abbreviations and Acronyms
CT 5 X-ray computed tomography
EBCT 5 electron beam computed tomography
ROC 5 receiver operating characteristic
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of disease (i.e., maximal angiographic stenosis) as the refer-
ence standard with any coronary calcium score $0 as the test
variable. ROC curve areas are reported as mean value 6SE
(i.e., the estimated standard “error” of the calculated ROC
curve area [trapezoidal rule] from the area that would have
been obtained with an infinite sample [15]). The significance of
any ROC curve area (A) from that of “chance” (area of 0.5
[9,13,15,16]) involved calculation of the z statistic: (z 5 [A 2
0.5]/SE) (16); the corresponding p value was then determined
from a look-up table.
Results
Angiography demonstrated maximal coronary diameter ste-
noses from 0% to 100%, with 24% of the patients having
normal coronary arteries (or at most trivial disease) and
another 23% with mild to moderate disease (maximal stenosis
$20% but ,50%). Thus, the angiographic spectrum of pa-
tients was 47% with, at most, “nonobstructive” disease and
53% with $50% diameter stenosis. The distribution of results
as a function of maximal coronary stenosis in any vessel and
the number of patients within each angiographic category are
given in Table 1. The arithmetic mean maximal diameter
stenosis (6SD) was 52 6 39%, and the median stenosis was
60%; the 25th percentile was 20% stenosis and the 75th
percentile was 90% stenosis. Calcium scores for the 213
patients ranged from 0 to 4,091. The arithmetic mean calcium
score was 440 6 756, and the median score was 107; the 25th
percentile was a score of 2 and the 75th percentile was a score
of 541.
ROC curves. Individual ROC curves were generated for
each decade of maximal angiographic disease from $20% to
100% stenosis in any segment of the major epicardial coronary
arteries (Fig. 1). Each data point corresponds to the sensitivity
and specificity of a particular calcium score for the specified
definition of disease. An area under the ROC curve of 0.5
would imply equity between true positive and false positive test
results (the equivalent of a random coin flip or chance). Curve
areas .0.5 represent tests with increasingly greater diagnostic
accuracy up to the “perfect” test (100% sensitive, 100%
specific) at a curve area of 1.0. Individual ROC curve areas
(6SE) are given in Table 2. All curve areas were statistically
different (p , 0.000001) from a curve area of 0.5 (i.e., for the
indeterminate test), suggesting a cogent application for coro-
nary calcium scoring as a means to predict the likely severity of
angiographic disease across all degrees of maximal lumen
narrowing examined. Although all curves were consistent with
a statistically valid use of EBCT calcium scores to predict
variable angiographic disease, the individual z statistics (Table
2) showed that the strongest application was for predicting the
presence of at least $20% stenosis at angiography (z 5 20.50),
and the weakest was for predicting the presence of at least
100% stenosis at angiography (z 5 11.30).
Figure 1. Individual ROC curves plotting (1 2 Specificity [12Sp]),
also called the false positive rate, versus sensitivity (Se), also called the
true positive rate, for each decade of angiographic stenosis. See text for
details.
Table 1. Distribution of Angiographic Disease Severity in 213
Consecutive Patients
Angio Disease Severity











Angio 5 angiographic; max 5 maximal.
Table 2. Area Under Receiver Operating Characteristic Curves for
Total Electron Beam Computed Tomographic Coronary Calcium






(mean 6 SE) z Value
$20% 0.91 6 0.02 20.50
$30% 0.89 6 0.02 17.37
$40% 0.90 6 0.02 20.31
$50% 0.90 6 0.02 18.18
$60% 0.90 6 0.02 17.96
$70% 0.88 6 0.02 16.10
$80% 0.86 6 0.02 14.06
$90% 0.83 6 0.03 12.34
100% 0.83 6 0.03 11.30
*See text for details. ROC 5 receiver operating characteristic; other
abbreviations as in Table 1.
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“Optimal” sensitivity and specificity of calcium scores for
angiographic disease. The ROC curve data list sensitivity and
specificity as a function of EBCT calcium score. The general
shape of the ROC curves is such that sensitivity and specificity
were inversely related; that is, for use of the EBCT coronary
calcium score, regardless of the severity of corresponding
angiographic stenoses, the test was most sensitive but least
specific when the calcium score was low and least sensitive but
most specific when the calcium score was high. “Optimal”
calcium score, which corresponds to the point at which sensi-
tivity and specificity are maximum for a given degree of
angiographic stenosis, can be defined as the maximal value of
the sum of sensitivity and specificity across all calcium scores.
Figure 2 demonstrates the graphic equivalent of this calcula-
tion. Plotted are individual calcium scores on the horizontal
axis and corresponding sensitivities and specificities on the
vertical axis. Figure 2 (top) plots part of the sensitivity and
specificity data for maximal angiographic stenosis of $40%,
whereas Figure 2 (bottom) plots a portion of the sensitivity and
specificity data for angiographic stenosis of $70%. The cal-
cium score at which the sensitivity and specificity data cross
defines the “optimal” calcium score for predicting the corre-
sponding associated degree of angiographic lumen narrowing.
This calculation was performed for all tabulated ROC data,
and Table 3 gives the optimal calcium scores and associated
sensitivities and specificities for each decade of angiographic
narrowing examined in this patient group. Values ranged from
74% to 85%.
Variable sensitivity and specificity of calcium scores for
angiographic disease. As benchmarks to predict the likely
severity of angiographic disease, the ROC tabular data were
evaluated to determine ranges of EBCT calcium scores corre-
sponding to 90% sensitivity (and associated specificity) and
those scores corresponding to 90% specificity (and associated
sensitivity). These data are given in Table 4.
Discussion
Sensitivity and specificity are common terms used to define
the applicability of noninvasive testing performed during the
evaluation of cardiac patients. Mostly these refer to application
of various “stress” tests, with or without adjunctive cardiac
imaging, to predict the presence of at least “significant”
coronary artery disease generally verified by direct comparison
with maximal stenoses determined by coronary angiography.
These tests are valid in many situations to predict the absence
or presence of coronary stenoses of $50% or $70%, depend-
ing on the study, but are not reliable in predicting the absence
or presence of maximal coronary lumen narrowing either
Figure 2. Graphic definition of “optimal” calcium score by plotting the
intersection of the sensitivity (Se) and specificity (Sp) curves from the
ROC curve analysis versus individual coronary calcium scores. Exam-
ples are given for predicting $40% angiographic stenosis (top) and
$70% angiographic stenosis (bottom).
Table 3. “Optimal” Electron Beam Computed Tomographic
Coronary Calcium Score Maximizing Sensitivity and Specificity for






Calcium Score Sens Spec
$20% 15 81% 81%
$30% 22 80% 80%
$40% 58 81% 81%
$50% 80 84% 84%
$60% 106 84% 85%
$70% 123 81% 81%
$80% 159 78% 78%
$90% 176 74% 74%
100% 327 75% 75%
EBCT 5 electron beam computed tomographic; Sens 5 sensitivity; Spec 5
specificity; other abbreviations as in Table 1.
Table 4. Cutpoints for Electron Beam Computed Tomographic
Coronary Calcium Scores for Sensitivity of 90% and Associated
Specificity and for Electron Beam Computed Tomographic
Quantified Coronary Calcium Scores for Specificity of 90% and
Associated Sensitivity as a Function of Decade of Associated
Maximal Angiographic Lumen Stenoses
Angio Disease Severity
(max % stenosis)





$20% 3 (73%) 27 (76%)
$30% 4 (61%) 89 (69%)
$40% 10 (64%) 110 (78%)
$50% 37 (77%) 168 (71%)
$60% 45 (77%) 194 (69%)
$70% 48 (73%) 376 (57%)
$80% 67 (69%) 545 (48%)
$90% 77 (64%) 711 (42%)
100% 154 (65%) 945 (40%)
Ca 5 calcium; other abbreviations as in Tables 1 and 3.
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below or above these thresholds. Based on the current analysis,
the following conclusions can be stated regarding analogous
use of quantitative EBCT coronary calcium scores. First, ROC
curve analysis demonstrated that there exist ranges of values
for EBCT calcium scores applicable to assessment of maximal
angiographic coronary lumen narrowing from $20% stenosis
(mild disease) through 100% stenosis. ROC curve areas
ranged from a high of 0.91 for mild narrowing to a low of 0.83
for occlusive disease, but all were significantly different from
chance. Second, a range of values for “optimal” coronary
calcium scores can be determined as nonoverlapping cutpoints,
which are associated with a high sensitivity and specificity
(.80% for both) for a range of coronary artery disease from
mild, to moderate, to significant, and with modest sensitivities
and specificities (74% to 78%) for critical and obstructive
disease. Third, specific nonoverlapping cutpoint values for
coronary calcium scores can also be determined, which are
either highly sensitive (90%) or highly specific (90%) for a
predefined range of associated angiographic lumen narrowing.
Thus, based on the current analysis, quantitative assessment of
coronary artery calcification and calcium “scoring” using
EBCT can be used to predict, with variable but generally high
sensitivity and specificity, the likely severity of anatomic coro-
nary artery disease across a broad spectrum from nonobstruc-
tive to obstructive and occlusive coronary artery disease.
Clinical interpretation and application of EBCT calcium
scores. A negative EBCT scan (i.e., no detectable mural
calcification) does not establish that coronary plaque is absent
(18), nor can it exclude the presence of a lipid-rich but unstable
plaque. In fact, the area of calcium quantified by EBCT is
roughly only one-fifth that of the total area of histologic plaque
(7). However, the negative predictive value of EBCT for fixed
“significant” coronary lumen obstructive disease is very high,
approaching 95% in some series (9,11); moreover, up to
two-thirds of men and women who have angiographically
normal arteries have no calcium on EBCT examination (9). A
positive EBCT study (i.e., presence of quantifiable mural
coronary calcium), in contrast, is 100% specific for atheroma-
tous coronary plaque (5,7,19). The current investigation has
attempted to expand these causal relations into calcium score
guidelines for positive studies that may be used to predict
coronary artery disease severity on an individual basis, using
the more commonly used clinical estimation of disease severity
based on maximal percent angiographic lumen stenosis.
It is our opinion that an EBCT scan for quantification of
coronary artery calcium should function only as an adjunct to
traditional evaluations or risk assessment, or both, and re-
quires interpretation in the clinical context of the patient’s
presentation. Only in this way will the absence, presence and
amount of coronary artery calcification allow for a potential
means to aid in the treatment of patients at risk for premature
coronary artery disease (18) or with chest pain syndromes.
Individuals without established or documented coronary artery
disease can present for evaluation in three broad areas: 1)
patients with new onset chest pain seen in the emergency
department; 2) patients with symptoms of chest pain or
unexplained dyspnea in the outpatient clinic; and 3) asymp-
tomatic but “high risk” patients who may or may not have
premature atherosclerotic disease. Each group presents a
different diagnostic challenge. In particular, the patient in the
emergency department may or may not have “significant”
coronary artery disease, but urgent triage to the home or
hospital or for further testing is required. In this case, a test
that is very sensitive to the presence of advanced or significant
coronary obstructive disease may be of value. The patient who
has, at most, a stable angina syndrome and who is otherwise
ambulatory may require testing that maximizes or “optimizes”
both the sensitivity and specificity for significant disease. The
asymptomatic but high risk patient, termed so because of the
presence of two or more cardiovascular risk factors, would
most likely be a candidate for a test with a very high specificity
(i.e., a low false positive rate) in predicting the presence of
moderate to severe coronary artery disease. EBCT assessments
of coronary artery calcium, depending on the absence of
calcium or the magnitude of the calcium score as examined in
the current study, could be of value to the clinician in each of
these patient groups, using ranges for coronary calcium scores
that are highly sensitive or maximize sensitivity and specificity
for obstructive disease, or are highly specific for moderate to
severe lumen disease.
Using information from Table 4, the emergency depart-
ment patient with a calcium score $37 would demonstrate at
least 90% sensitivity for $50% coronary stenosis. Alterna-
tively, as discussed earlier, a zero calcium score would give a
negative predictive value of 90% to 95%. Thus, if no calcium
was observed, the presence of $50% fixed stenosis would be
remote. In contrast, a calcium score .0 but ,37 may suggest
that the patient needs a period of observation (perhaps in a
chest pain unit), whereas a calcium score $37 might suggest
the need for further noninvasive or invasive testing or admis-
sion to the hospital.
Using information from Table 3, the ambulatory but symp-
tomatic patient with a calcium score $80 would demonstrate
84% sensitivity and 84% specificity for $50% stenosis. These
values for sensitivity and specificity are comparable to conven-
tional outpatient stress testing methods. However, the advan-
tages of EBCT are that, if available, it can be done quickly
(total testing time of 10 to 15 min), it is diagnostic even if the
patient has an abnormal rest electrocardiogram or is concur-
rently taking cardiotonic medications (e.g., beta-blockers,
digoxin) and the cost is approximately one-half that of stress
echocardiography and one-third that of stress thallium scintig-
raphy (18).
In a 10-year follow-up study of 521 patients who were
normal or had, at most, nonobstructive coronary artery disease
at the time of initial coronary angiography, Proudfit et al. (20)
found an all-cause mortality rate of 6% for patients with ,30%
stenosis, compared with a 25% all-cause mortality rate for
those with $30% but ,50% stenosis. In addition, the inci-
dence of any cardiac events (death, arteriographic progression
to obstruction, myocardial infarction) over the next 10 years
was 2.1% in those with normal angiograms, increasing to
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13.8% with ,30% stenosis, and to 33% in those with 30% to
50% maximal stenoses. Using information from Table 4, a
patient would have 90% specificity for moderate anatomic
(nonobstructive) coronary artery disease (i.e., $30% to $40%
stenosis) with a calcium score between 89 and 110. Subject to
the limitations discussed subsequently, this range of cutpoints
could potentially be applicable for long-range prognostication
to the “high risk” patient who had no previous history of
disease. Such individuals may be candidates for targeted
aggressive risk factor modification, including use of high priced
lipid-lowering drugs, if appropriate. Recent investigations by
Detrano et al. (21), in angiographically studied patients, have
suggested a threshold calcium score of .100 as an indepen-
dent factor representing increased short-term (24 months) risk
for a cardiac event, whereas Arad et al. (22) have shown a
score of $160 to provide for increased short-term (19 months)
risk in asymptomatic patients.
Study limitations. The analyses presented here are from
only 213 patients who were highly selected for participation in
our original study (9,12), and the data given in Tables 3 and 4
should be considered only as estimates of what may be found
in a larger population. None of the patients had a previous
diagnosis of coronary artery disease, and they were generally
middle aged; thus, broad application to other age groups
should be done with caution. Two recent reports from our
laboratory, one a histopathologic study (13) and the other a
clinical study (9), have shown that EBCT coronary calcium has
a similar predictive value in men and women when matched for
the extent of coronary lumen narrowing (although there are
still differences in the extent of disease in men and women at
a given age). Thus, cutpoints for calcium scoring, as presented,
are considered to be applicable to women as well as to men
because women with any particular set of calcium scores tend
to have the same amount of angiographic coronary disease as
men with similar scores.
An additional issue is that comparisons with patients un-
dergoing clinically indicated angiography could favor evalua-
tion of patients with more advanced coronary disease and may
not permit estimations of disease severity with all possible
coronary calcium scores, owing to a lack of correlations
performed across the entire anatomic spectrum of disease.
However, in fact, the angiographic distribution of disease in
the patients studied ranged from none or trivial coronary
disease through nonobstructive, obstructive and occlusive dis-
ease. Nearly 50% of the patients had, at most, nonobstructive
disease with a broad, albeit nonnormal, distribution across all
subgroups above and below this threshold (Table 1). Twenty-
four percent of patients had normal or nearly normal coronary
arteries and 19% had occlusive (100% maximal stenosis)
disease. Thus, the current study group is representative of a
comprehensive range of anatomic disease severity, as might be
seen in a group of middle-aged patients undergoing evaluation
for cardiac disease.
Seventy-five percent of the patients examined had symp-
toms of “angina” before coronary angiography. Another pos-
sible limitation of the study could relate to the validity of
predicting the lumen severity of disease using calcium scores
from Tables 3 and 4 in an asymptomatic rather than a
symptomatic patient. However, definitions of coronary anat-
omy should not be confused with definitions of coronary
physiology. The absence or presence of ,50% or $50% lumen
stenosis does not rule in or rule out inducible ischemia, it only
indicates that it is less likely with the former and more likely
with the latter. The presence of coronary calcium implies the
anatomic presence of atherosclerotic plaque; it implies nothing
about the physiologic response of the individual to the pres-
ence or amount of atherosclerotic plaque. A host of confound-
ing factors can influence the absence or presence of symptoms
such as diabetes, left ventricular hypertrophy and various
cardiotonic medications. In fact, a recent report by Guerci et
al. (23) has demonstrated a significant correlation between
EBCT calcium score and maximal percent lumen stenosis in a
small group of asymptomatic patients undergoing diagnostic
angiography. Just the same, application of the calcium cut-
points reported in the current investigation for evaluation of
asymptomatic patients must be done with caution and only in
the context of additional clinical information.
Finally, there are limitations in the application of EBCT
and calcium scoring. Although calculation of the total calcium
score using EBCT is quantitative (8–12,24) and operator
independent (25), reproducibility varies from excellent (26) to
moderate (27), depending on the laboratory. Thus, it is possi-
ble with application of EBCT that calcium scores above or
below the values given in Tables 3 and 4 may prove to be more
appropriate in broad clinical practice. The calcium score values
should be interpreted as ranges and not absolutes.
Conclusions. The current study has attempted to define
ranges for EBCT-quantified coronary calcium scores that can
be used to predict the likely severity of associated anatomic
coronary disease as measured by direct coronary angiography.
Potential applications of these various cutpoints, as deter-
mined from ROC curve analysis, are dependent on the clinical
situation and the question that the clinician is trying to answer.
These clinical situations then dictate the ranges for EBCT
calcium scores employed as being highly sensitive, maximally
sensitive and specific or highly specific for a predetermined or
expected “disease” severity. The incremental value of EBCT
calcium scanning in a given patient cannot be determined from
the current data set, but these data form a foundation to
pursue this issue to its next logical step. However, it must be
emphasized that EBCT coronary calcium scores are not a
substitute for coronary angiography, and these guidelines are
meant to function only as adjuncts to traditional evaluations of
patients suspected of having coronary artery disease.
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